← FDA Drug Approvals (Drugs@FDA)

MESALAMINE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: ZYDUS PHARMS · Approved 2020-02-12

Drug application

FDA Application #

ANDA208953

Application type

Abbreviated New Drug Application (Generic)

Brand name

MESALAMINE

Generic name

MESALAMINE

Active ingredients

MESALAMINE

Dosage form

SUPPOSITORY

Route

RECTAL

Marketing status

Prescription

Sponsor

ZYDUS PHARMS

Manufacturer

Northstar Rx LLC.

First approval

2020-02-12

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown